Altered monocyte calcium-sensing receptor expression in patients with type 2 diabetes mellitus and atherosclerosis

Journal of Physiology and Pharmacology

Volumn 64, Issue 4, 2013, Pages 521-527

  Malecki, R ^a   Fiodorenko Dumas, Z ^a   Jakobsche Policht, U ^a   Malodobra, M ^a   Adamiec, Rafal ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; Calcium sensing receptor; Diabetes mellitus type 2; Monocytes; Peripheral arterial disease

Indexed keywords

CALCIUM SENSING RECEPTOR; CYTOKINE; GLUCOSE; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN;

ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN EXPRESSION;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, CALCIUM-SENSING;

EID: 84884944389     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009; 119: 3078-3084.
2. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 1998; 21: 539-545.
3. Elhadd TA, Robb R, Jung RT, Stonebridge P, Belch J. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diabetes Int 1999; 16: 163-166.
4. Blanes JI, Cairols MA, Marrugat J. Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study. Int Angiol 2009; 28: 20-25.
5. Liang CP, Han S, Senokuchi T, Tall AR. The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res 2007; 100: 1546-1555.
6. Mita T, Goto H, Azuma K, et al. Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level. Biochem Biophys Res Commun 2010; 395: 477-483.
7. Gappa-Fahlenkamp H, Shukla. The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro human vascular tissue model. In Vitro Cell Dev Biol Anim 2009; 45: 234-242.
8. Meng L, Park J, Cai Q, Lanting L, Reddy MA, Natarajan R. Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation. Am J Physiol Heart Circ Physiol 2010; 298: H736-H745.
9. Cui X, Kushiyama A, Yoneda M, et al. Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy. Diabetes Res Clin Pract 2010; 87: 57-63.
10. Dragomir E, Simionescu M. Monocyte chemoattractant protein-1-a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006; 112: 239-244.
11. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-380.
12. Yamaguchi T, Olozak I, Chattopadhyay N, et al. Expression of extracellular calcium (Ca2+o)-sensing receptor in human peripheral blood monocytes. Biochem Biophys Res Commun 1998; 246: 501-506.
13. Greenland P, Abrams J, Aurigemma GP, et al. Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Prevention Conference V. Writing Group III. Circulation 2000; 101: E16-E22.
14. Schuhfried O, Wiesinger G, Kollmitzer J, Mittermaier C, Quittan M. Fourier analysis of impedance rheography for peripheral arterial occlusive disease. Eur J Appl Physiol 2003; 89: 384-386.
15. Malecki R, Adamiec R, Jakobsche U. Expression of extracellular calcium-sensing receptor in peripheral blood monocytes in patients with arteriosclerosis obliterans, diabetes mellitus type 2 complicated with macroangiopathy in the context of the selected proinflammatory factors. Exp Clin Diabetol 2007; 7: 235-239.
16. Alam MU, Kirton JP, Wilkinson FL, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 2009; 81: 260-268.
17. Li T, Sun M, Yin X, et al. Expression of the calcium sensing receptor in human peripheral blood T lymphocyte and its contribution to cytokine secretion through MAPKs or NF-kB pathways. Mol Immunol 2012; 53: 414-420.
18. Olszak IT, Poznansky MC, Evans RH, et al. Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 2000; 105: 1299-1305.
19. Krysiak R, Okopien B. Different effects of simvastatin on ex vivo monocyte cytokine release in patients with hypercholesterolemia and impaired glucose tolerance. J Physiol Pharmacol 2010; 61: 725-732.
20. 2+is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun 2012; 3: 1329.
21. 2+and cAMP. Nature 2012; 492(7427): 123-127.
22. Aiello RJ, Bourassa P-AK, Lindsey S, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 1518-1525.
23. Piemonti L, Calori G, Lattuada G, et al. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals. Diabetes Care 2009; 32: 2105-2110.
24. Zheng W, Li R, Pan H, et al. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1b through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis Rheum 2009; 60: 1957-1765.
25. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
26. Cho HJ, Cho HJ, Kim HS. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 2009; 11: 206-213.
27. Dimitriadis G, Maratou E, Boutati E, Psarra K, Papasteriades C, Raptis SA Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 2005; 64: 27-33.
28. Malide D, Davies-Hill TM, Levine M, Simpson IA. Distinct localization of GLUT-1,-3, and-5 in human monocytederived macrophages: effects of cell activation. Am J Physiol 1998; 274: E516-E526.
29. Liang CP, Han S, Senokuchi T, Tall AR. The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res 2007; 100: 1546-1555.
30. Ward DT. Calcium receptor-mediated intracellular signalling. Cell Calcium 2004; 35: 217-228.
31. Demkow U, Winklewski P, Potapinska O, Popko K, Lipinska A, Wasik M. Kinetics of calcium ion concentration accompanying transduction of signals into neutrophils from diabetic patients and its modification by insulin. J Physiol Pharmacol 2009: 60(Suppl. 5): 37-40.